ClavystBio

ClavystBio is a leading investment management firm dedicated to accelerating health impact through strategic investments and venture building. With a strong focus on life sciences, ClavystBio partners with innovators, entrepreneurs, and founders to transform breakthrough ideas into commercially viable solutions. ClavystBio is committed to fostering both private and public partnerships to launch and grow global companies from Singapore.

Located at 79 Science Park Drive, #04-05 Cintech IV, Singapore Science Park, Singapore, 118264, SG, ClavystBio specializes in therapeutics, digital health, and MedTech, emphasizing first-in-class science and technology. The collaborative space, Node 1, provides essential infrastructure and a supportive community for life science startups ready to advance to their next milestones. Since its inception in 2022, ClavystBio has committed over $220 million in investments, demonstrating its dedication to the life sciences sector.

ClavystBio continues to drive innovation and growth within the health and life sciences industries. The firm's forward-thinking approach and strategic investments are positioning ClavystBio as a key player in the global health ecosystem. ClavystBio is constantly seeking new opportunities to expand its portfolio and impact, further solidifying its role as a catalyst for health innovation. We invite the manager of ClavystBio to create a customized and exclusive company showcase and product listing on our platform.